South Korea · Delayed Price · Currency is KRW SD Biosensor Statistics
Total Valuation
SD Biosensor has a market cap or net worth of KRW 740.44 billion. The enterprise value is 585.98 billion.
| Market Cap | 740.44B |
| Enterprise Value | 585.98B |
Important Dates
The next estimated earnings date is Saturday, November 14, 2026.
| Earnings Date | Nov 14, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
SD Biosensor has 119.62 million shares outstanding. The number of shares has decreased by -1.07% in one year.
| Current Share Class | 119.62M |
| Shares Outstanding | 119.62M |
| Shares Change (YoY) | -1.07% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 32.51% |
| Owned by Institutions (%) | 2.53% |
| Float | 32.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | 66.53 |
| P/OCF Ratio | 13.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.43, with an EV/FCF ratio of 52.65.
| EV / Earnings | n/a |
| EV / Sales | 0.79 |
| EV / EBITDA | 12.43 |
| EV / EBIT | n/a |
| EV / FCF | 52.65 |
Financial Position
The company has a current ratio of 6.51, with a Debt / Equity ratio of 0.12.
| Current Ratio | 6.51 |
| Quick Ratio | 4.21 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 4.82 |
| Debt / FCF | 25.98 |
| Interest Coverage | -0.73 |
Financial Efficiency
Return on equity (ROE) is -26.90% and return on invested capital (ROIC) is -2.97%.
| Return on Equity (ROE) | -26.90% |
| Return on Assets (ROA) | -1.21% |
| Return on Invested Capital (ROIC) | -2.97% |
| Return on Capital Employed (ROCE) | -2.38% |
| Weighted Average Cost of Capital (WACC) | 12.82% |
| Revenue Per Employee | 1.28B |
| Profits Per Employee | -1.27B |
| Employee Count | 576 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.64 |
Taxes
| Income Tax | -63.58B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.22% in the last 52 weeks. The beta is 0.71, so SD Biosensor's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -38.22% |
| 50-Day Moving Average | 6,293.00 |
| 200-Day Moving Average | 7,907.15 |
| Relative Strength Index (RSI) | 47.66 |
| Average Volume (20 Days) | 241,799 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SD Biosensor had revenue of KRW 738.76 billion and -729.49 billion in losses. Loss per share was -6,094.00.
| Revenue | 738.76B |
| Gross Profit | 341.00B |
| Operating Income | -65.80B |
| Pretax Income | -794.66B |
| Net Income | -729.49B |
| EBITDA | 59.92B |
| EBIT | -65.80B |
| Loss Per Share | -6,094.00 |
Balance Sheet
The company has 449.51 billion in cash and 289.12 billion in debt, with a net cash position of 160.40 billion or 1,340.88 per share.
| Cash & Cash Equivalents | 449.51B |
| Total Debt | 289.12B |
| Net Cash | 160.40B |
| Net Cash Per Share | 1,340.88 |
| Equity (Book Value) | 2.41T |
| Book Value Per Share | 19,969.33 |
| Working Capital | 773.01B |
Cash Flow
In the last 12 months, operating cash flow was 56.74 billion and capital expenditures -45.61 billion, giving a free cash flow of 11.13 billion.
| Operating Cash Flow | 56.74B |
| Capital Expenditures | -45.61B |
| Depreciation & Amortization | 125.72B |
| Net Borrowing | -417.60B |
| Free Cash Flow | 11.13B |
| FCF Per Share | 93.04 |
Margins
Gross margin is 46.16%, with operating and profit margins of -8.91% and -98.75%.
| Gross Margin | 46.16% |
| Operating Margin | -8.91% |
| Pretax Margin | -107.57% |
| Profit Margin | -98.75% |
| EBITDA Margin | 8.11% |
| EBIT Margin | -8.91% |
| FCF Margin | 1.51% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 3.25%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 3.25% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.07% |
| Shareholder Yield | 4.32% |
| Earnings Yield | -98.52% |
| FCF Yield | 1.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SD Biosensor has an Altman Z-Score of 2.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | 4 |